Sci Rep. 2017 Jun 1;7(1):2667. doi: 10.1038/s41598-017-02947-y.

Isolated Congenital Anosmia and CNGA2 Mutation.

Sailani MR¹, Jingga I¹, MirMazlomi SH², Bitarafan F², Bernstein JA³, Snyder MP⁴, Garshasbi M^5,⁶.

Author information

1: Department of Genetics, Stanford University, Stanford, CA, USA.
2: Medical Genetics Department, DeNA laboratory, Tehran, Iran.
3: Department of Pediatrics, Stanford University, Stanford, CA, USA.
4: Department of Genetics, Stanford University, Stanford, CA, USA. mpsnyder@stanford.edu.
5: Medical Genetics Department, DeNA laboratory, Tehran, Iran. masoud.garshasbi@modares.ac.ir.
6: Department of Medical Genetics, Tarbiat Modares University, Teheran, Iran. masoud.garshasbi@modares.ac.ir.

Abstract

Isolated congenital anosmia (ICA) is a rare condition that is associated with life-long inability to smell. Here we report a genetic characterization of a large Iranian family segregating ICA. Whole exome sequencing in five affected family members and five healthy members revealed a stop gain mutation in CNGA2 (OMIM 300338) (chrX:150,911,102; CNGA2. c.577C > T; p.Arg193*). The mutation segregates in an X-linked pattern, as all the affected family members are hemizygotes, whereas healthy family members are either heterozygote or homozygote for the reference allele. cnga2 knockout mice are congenitally anosmic and have abnormal olfactory system physiology, additionally Karstensen et al. recently reported two anosmic brothers sharing a CNGA2 truncating variant. Our study in concert with these findings provides strong support for role of CNGA2 gene with pathogenicity of ICA in humans. Together, these results indicate that mutations in key olfactory signaling pathway genes are responsible for human disease.